K. Raslová
Department of Lipid and Glucose Metabolism
Institute of Preventive and Clinical Medicine
Bratislava
Slovak Republic
Name/email consistency: high
- Apolipoprotein E genotypes in offspring with a positive and negative family history of premature myocardial infarction. Raslová, K., Smolková, B., Vohnout, B., Schifferdecker, B., Poledne, R., Dusinská, M. Clin. Genet. (1998)
- Ciprofibrate treatment in patients with atherogenic lipoprotein phenotype: effects on HDL quality, LDL susceptibility to oxidation and DNA damage. Raslová, K., Dobiásová, M., Nagyová, A., Fábry, R., Rauchová, H., Dusinská, M. Eur. J. Clin. Pharmacol. (1998)
- Relationship between plasma fenofibric acid levels and the effect of micronized fenofibrate on cholesterol, low-density-lipoprotein cholesterol and apolipoprotein B in patients with primary hypercholesterolemia. Raslová, K., Dubovská, D., Mongiellová, V., Trnovec, T. Eur. J. Clin. Pharmacol. (1997)